From: Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework
PRECIS-2 domain | Original protocol | Protocol refinement | Reason for refinement |
---|---|---|---|
Eligibility | • Patients are adults with type 2 diabetes who are existing patients of the practice; excludes pregnancy or plans to become pregnant within 6 months, life expectancy less than 6 months, cognitive inability to participate, plans to leave area within next year. | • Practices encouraged to recruit any adult with type 2 diabetes they believed would be able to participate in and benefit from SMAs (i.e., no explicit assessment of eligibility criteria; providers review lists of patients to assess suitability) • Pregnancy exclusion criterion would be applied analytically based on EHR data. | • Not typical for practices to ask patients if planning to become pregnant or leave the area prior to offering care; • Assessment of cognitive ability, life expectancy, and other “suitability” factors based on provider judgment |
Recruitment | • Practices would recruit patients using existing personnel and processes of care | • Practices shared strategies used to meet recruitment goals during practice stakeholder calls. • Engaged patient stakeholders helped develop marketing materials. • Research team provided recruitment fliers and coaching sessions to support recruitment strategies. | • Recruitment was listed as a top barrier from every practice and they needed extra support and guidance to achieve recruitment goals. |
Setting | • Diverse clinic settings: FQHCs, private practices, and community mental health centers with integrated behavioral health and primary care, including small/large and urban/suburban/rural sites in Colorado. • Practices had ≥100 adult patients with type 2 diabetes (able to commit to 72 patients over 2 years, including 60 with complete PRO data) | • No community mental health centers recruited • Allowed “half-sites” to provide 36 patients instead of 72 • Allowed participating organizations to combine smaller practices into one “site” for randomization purposes | • Policy-level changes to billing/payment structures for community mental health centers came into effect during practice recruitment. • Smaller practices allowed to participate to reach practice recruitment goals and to ensure results were relevant to a greater range of practice sizes |
Organization | • Existing personnel required prescribing providers (MDs/DOs), integrated behavioral health providers (master’s and doctoral level), health educators (nurse, health educators or certified diabetes educators), and SMA coordinators. • Patient-driven practices required to identify existing patients with type 2 diabetes to serve as peer mentors • SMAs paid for through billing for prescribing provider office visits. | • Prescribing providers could include PharmDs • Health educators could include Medical Assistants or Community Health Workers, if properly supervised | • PharmDs are also able to provide medication management and can bill for services • Not all practices had formally trained health educators on staff • Not all practices required prescribing provider visits to pay for services |
Flexibility-Delivery | • Practices randomized to patient driven or standardized SMA condition and follow delivery core components according to assigned arm • Must use the TTIM curriculum with no additional content • Medical provider addresses medical management needs in group session for 20 min • Once a week for 12 weeks for 60 min sessions in person. • 8–10 patients per cohort | • 6 session model (each 90 min to 2 h in length) • Health educator may also include trained lay personnel (e.g., community health workers, medical assistants) • Medical provider may also include pharmacists • Prescribing provider may meet individually with patients for 5–10 min at some or all sessions • Practices enrolled later in the study may reach fewer patients | • Less burdensome for practices to deliver a 6 session model, which may also support retention • To accommodate staffing demands, availability, and need for Spanish-speaking personnel • Some practices prefer pharmacists meet with patients for diabetes management needs, given large role of medication in diabetes care • Individual visits with medical provider supports higher reimbursement rates toward costs of delivering diabetes SMAs • Practices enrolled later in the study have less time to reach initial goals for recruitment |
Delivery-Adherence | • Practice facilitation and observation support fidelity | • Established core vs. flexible components of diabetes SMAs to gauge fidelity • Homework: Leave it up to the practice if they assign homework. | • Practices have different priorities and resources for delivering diabetes SMAs |
Follow-up | • PROs required at start and end • Retention efforts conducted as in usual clinical care (e.g., reminder and follow up calls) • Participation included as an outcome (differences in conditions for reach and engagement) | • To get follow-up PROs, practices can call to get these data from patients who do not attend the final SMA session • For patient-driven diabetes SMAs, peer mentors may assist with encouraging patients to attend all SMA sessions • Practices not required to track patients who refused invitation to SMAs | • Difficulties in completing PROs at sessions due to limited time or patient no-show • Overly burdensome for practices to track who they invited to SMAs (they might have a master list of who they contacted and invited - most have a spreadsheet they use to track who they’ve contacted but we do not ask them to report this data) |
Outcomes | • 17-item Diabetes Distress Scale (DDS-17); 6-item Health Care Climate Questionnaire (HCCQ); 5-item EQ-5D; 11-item Summary of Diabetes Self-Care Activities (SDSCA); 14-item self-report measure in the Health LiTT tool (53 total survey items) • Surveys administered at first and last sessions • Select items from the Medical Expenditure Panel Survey, National Health Survey, and American Time Use Survey for select patients to assess patient out-of-pocket cost | • PROs for assessment during sessions now limited to 45 survey items • Added Perceived Confidence Scale • 3-item Brief Health Literacy screener instead of Health LiTT • Removed EQ-5D • Baseline surveys administered during first session attended (i.e., the second session for a patient who missed the first sessions) • Follow up surveys administered by phone or mail for patients who did not attend the last session • PROs collected using online survey platforms • Out-of-pocket cost questionnaire assessed among select patients verbally during patient interviews | • Need to limit burden to patients in completing surveys, while minimizing time needed to measure outcomes during sessions • Reprioritizing measures of value and importance to stakeholders • Need to collect baseline surveys for patients who miss the first session; • Need to collect follow up surveys for patients who stop attending • Surveys previously collected on paper were no longer feasible with vSMAs • Reduced burden for practice to recruit for non-PRO surveys; reduced burden for patient to provide responses to study team |
Analysis | • Intent to treat analysis • 10 practices per arm (20 total) • 72 patients enrolled per practice (720 per arm) | • Increased number of sites to 22 • Reduced patient enrollment requirements to 36 | • Additional sites needed to accommodate half-sites and retain patient recruitment goals (e.g., two half-sites equal 1 full site) |